Citadel Advisors’s GMO Ultra-Short Income ETF GMOC Stock Holding History

Citadel Advisors’s Portfolio GMOC Stock Details GMOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$483K	Sell	9,660 -1,599	-14%	-$80.1K	﹤0.01%	9398
2025 Q4	$563K	Buy	+11,259	New	+$564K	﹤0.01%	8738

Other funds holding GMOC

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

BPWM

BCS Private Wealth Management Rumson, New Jersey $332M AUM 23.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's GMOC Position: Q1 2026 in Review

Citadel Advisors reduced its GMO Ultra-Short Income ETF (GMOC) stake by 14% in Q1 2026, selling an estimated $80.1K and leaving 9,660 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #9398.

Citadel Advisors first reported a position in GMOC in Q4 2025 and has held it in 2 quarters since. The position peaked at $563K in Q4 2025. 4 funds tracked by Wall St. Rank hold GMOC as of Q1 2026.

Citadel Advisors held 9,660 shares of GMO Ultra-Short Income ETF worth $483K as of Q1 2026.
Citadel Advisors sold 1,599 GMO Ultra-Short Income ETF shares in Q1 2026, an estimated $80.1K.
GMO Ultra-Short Income ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9398 holding.
Citadel Advisors first reported a position in GMO Ultra-Short Income ETF in Q4 2025 and has held it in 2 quarters since.
Citadel Advisors's GMO Ultra-Short Income ETF position peaked at $563K in Q4 2025.
4 funds tracked by Wall St. Rank held GMO Ultra-Short Income ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.